News PTC Therapeutics Announces Agreement to Monetize a Portion of the Risdiplam Royalty Stream for $650 Million Jul 20, 2020 Posted by PTC Therapeutics, Inc.
News Webinar: Supporting Clinical Trial Site Selection During the COVID-19 Pandemic Using WAVE, a Hybrid Epidemiologic Model Jul 17, 2020
News Invivoscribe Launches New Division for Drug Development. Licenses Small Molecule Inhibitors from Domainex to Treat Acute Myeloid Leukemia. Jul 16, 2020
